| |
| |
|
| Insider
Information: |
Carpenter Christopher L. |
| Relationship: |
Chief Medical Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
34,843 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,986 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
34,843 |
|
|
| Total
Value |
$1,986 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rubius Therapeutics, Inc. |
RUBY |
Chief Medical Officer |
2019-12-16 |
34,843 |
2019-01-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-12-16 |
4 |
AS |
$13.48 |
$646,901 |
D/D |
(48,000) |
34,843 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-12-16 |
4 |
OE |
$2.87 |
$137,760 |
D/D |
48,000 |
82,843 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-09-17 |
4 |
AS |
$10.05 |
$119,309 |
D/D |
(11,877) |
34,843 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-09-17 |
4 |
OE |
$2.87 |
$34,087 |
D/D |
11,877 |
46,720 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-09-16 |
4 |
AS |
$10.13 |
$365,897 |
D/D |
(36,123) |
34,843 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-09-16 |
4 |
OE |
$2.87 |
$103,673 |
D/D |
36,123 |
70,966 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-06-20 |
4 |
AS |
$13.93 |
$3,386 |
D/D |
(243) |
34,843 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-06-20 |
4 |
OE |
$2.87 |
$697 |
D/D |
243 |
35,086 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-06-19 |
4 |
AS |
$13.80 |
$253,868 |
D/D |
(18,399) |
34,843 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-06-19 |
4 |
OE |
$2.87 |
$52,805 |
D/D |
18,399 |
53,242 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-06-18 |
4 |
AS |
$14.27 |
$154,958 |
D/D |
(10,858) |
34,843 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-06-18 |
4 |
OE |
$2.87 |
$31,162 |
D/D |
10,858 |
45,701 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-06-17 |
4 |
AS |
$14.10 |
$260,869 |
D/D |
(18,500) |
34,843 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-06-17 |
4 |
OE |
$2.87 |
$53,095 |
D/D |
18,500 |
53,343 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-03-15 |
4 |
AS |
$15.84 |
$760,114 |
D/D |
(48,000) |
34,843 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-03-15 |
4 |
OE |
$2.87 |
$137,760 |
D/D |
48,000 |
82,843 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2019-01-22 |
4 |
OE |
$2.87 |
$99,999 |
D/D |
34,843 |
34,843 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
